» Articles » PMID: 36461887

Emerging Mitochondrial-mediated Mechanisms Involved in Oligodendrocyte Development

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2022 Dec 3
PMID 36461887
Authors
Affiliations
Soon will be listed here.
Abstract

Oligodendrocytes are the myelinating glia of the central nervous system and are generated after oligodendrocyte progenitor cells (OPCs) transition into pre-oligodendrocytes and then into myelinating oligodendrocytes. Myelin is essential for proper signal transmission within the nervous system and axonal metabolic support. Although the intrinsic and extrinsic factors that support the differentiation, survival, integration, and subsequent myelination of appropriate axons have been well investigated, little is known about how mitochondria-related pathways such as mitochondrial dynamics, bioenergetics, and apoptosis finely tune these developmental events. Previous findings suggest that changes to mitochondrial morphology act as an upstream regulatory mechanism of neural stem cell (NSC) fate decisions. Whether a similar mechanism is engaged during OPC differentiation has yet to be elucidated. Maintenance of mitochondrial dynamics is vital for regulating cellular bioenergetics, functional mitochondrial networks, and the ability of cells to distribute mitochondria to subcellular locations, such as the growing processes of oligodendrocytes. Myelination is an energy-consuming event, thus, understanding the interplay between mitochondrial dynamics, metabolism, and apoptosis will provide further insight into mechanisms that mediate oligodendrocyte development in healthy and disease states. Here we will provide a concise overview of oligodendrocyte development and discuss the potential contribution of mitochondrial mitochondrial-mediated mechanisms to oligodendrocyte bioenergetics and development.

Citing Articles

Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis.

Kaufmann W, Luu S, Budimirovic D Curr Neurol Neurosci Rep. 2024; 25(1):7.

PMID: 39641900 DOI: 10.1007/s11910-024-01394-3.


Mitochondrial network reorganization and transient expansion during oligodendrocyte generation.

Bame X, Hill R Nat Commun. 2024; 15(1):6979.

PMID: 39143079 PMC: 11324877. DOI: 10.1038/s41467-024-51016-2.


Glycolytic dysregulation in Alzheimer's disease: unveiling new avenues for understanding pathogenesis and improving therapy.

Wu Y, Yang L, Jiang W, Zhang X, Yao Z Neural Regen Res. 2024; 20(8):2264-2278.

PMID: 39101629 PMC: 11759019. DOI: 10.4103/NRR.NRR-D-24-00190.


Brain development and bioenergetic changes.

Rajan A, Fame R Neurobiol Dis. 2024; 199:106550.

PMID: 38849103 PMC: 11495523. DOI: 10.1016/j.nbd.2024.106550.


Metabolic network analysis of pre-ASD newborns and 5-year-old children with autism spectrum disorder.

Lingampelly S, Naviaux J, Heuer L, Monk J, Li K, Wang L Commun Biol. 2024; 7(1):536.

PMID: 38729981 PMC: 11549098. DOI: 10.1038/s42003-024-06102-y.


References
1.
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View

2.
Poitelon Y, Kopec A, Belin S . Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism. Cells. 2020; 9(4). PMC: 7226731. DOI: 10.3390/cells9040812. View

3.
Buss R, Sun W, Oppenheim R . Adaptive roles of programmed cell death during nervous system development. Annu Rev Neurosci. 2006; 29:1-35. DOI: 10.1146/annurev.neuro.29.051605.112800. View

4.
Winkler C, Franco S . Loss of Shh signaling in the neocortex reveals heterogeneous cell recovery responses from distinct oligodendrocyte populations. Dev Biol. 2019; 452(1):55-65. PMC: 6594407. DOI: 10.1016/j.ydbio.2019.04.016. View

5.
Meyer N, Rinholm J . Mitochondria in Myelinating Oligodendrocytes: Slow and Out of Breath?. Metabolites. 2021; 11(6). PMC: 8226700. DOI: 10.3390/metabo11060359. View